Cingulate: This Novel Drug Technology May Soon Relieve A Patient's "Pill-Burden"

Cingulate is a clinical-stage biopharmaceutical company focused on the development of innovative new product candidates for the treatments of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety-associated disorders.